110 related articles for article (PubMed ID: 2906627)
1. Characteristics of cell mediating spontaneous resistance to bone marrow allografts.
Miller SC; Poirier L
Immunobiology; 1988 Dec; 178(3):191-202. PubMed ID: 2906627
[TBL] [Abstract][Full Text] [Related]
2. Genetically determined resistance to foreign bone marrow transplantation in mice: characterization of the effector cells.
Miller SC
J Immunol; 1983 Jul; 131(1):92-7. PubMed ID: 6345669
[TBL] [Abstract][Full Text] [Related]
3. Effects of Thy-1+ cell depletion on the capacity of donor lymphoid cells to induce tolerance across an entire MHC disparity in sublethally irradiated adult hosts.
Pierce GE; Watts LM
Transplantation; 1989 Aug; 48(2):289-96. PubMed ID: 2569241
[TBL] [Abstract][Full Text] [Related]
4. Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized.
Murphy WJ; Kumar V; Bennett M
J Exp Med; 1987 Nov; 166(5):1499-509. PubMed ID: 3316472
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of hybrid resistance by 5-fluorouracil. Destruction of a Thy-1+ Lyt-1+2- spleen cell implicated in the expression of hybrid resistance.
Kosmatopoulos K; Bravo-Cuellar A; Wachowiak J; Orbach-Arbouys S
Transplantation; 1987 Aug; 44(2):202-8. PubMed ID: 2888223
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of genetic resistance to friend virus leukemia in mice.
Kumar V; Bennett M; Eckner RJ
J Exp Med; 1974 May; 139(5):1093-109. PubMed ID: 4596510
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic versus semiallogeneic F1 bone marrow transplantation into sublethally irradiated MHC-disparate hosts. Effects on mixed lymphoid chimerism, skin graft tolerance, host survival, and alloreactivity.
Pierce GE
Transplantation; 1990 Jan; 49(1):138-44. PubMed ID: 2137269
[TBL] [Abstract][Full Text] [Related]
8. The effect of bearing tumours on the ability of mice to reject bone marrow transplants.
Miller SC; Nguyen D; Bird IA
Scand J Immunol; 1988 Apr; 27(4):427-32. PubMed ID: 3283920
[TBL] [Abstract][Full Text] [Related]
9. Loss of F1 hybrid resistance to bone marrow grafts after injection of parental lymphocytes. Demonstration of parental anti-F1 T killer cells and general immunosuppression in the host.
Knobloch C; Dennert G
Transplantation; 1988 Jan; 45(1):175-83. PubMed ID: 3276048
[TBL] [Abstract][Full Text] [Related]
10. Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice.
Morton JI; Siegel BV
Proc Natl Acad Sci U S A; 1974 Jun; 71(6):2162-5. PubMed ID: 4601580
[TBL] [Abstract][Full Text] [Related]
11. Ly-49 G2+ NK cells are responsible for mediating the rejection of H-2b bone marrow allografts in mice.
Raziuddin A; Longo DL; Mason L; Ortaldo JR; Murphy WJ
Int Immunol; 1996 Dec; 8(12):1833-9. PubMed ID: 8982767
[TBL] [Abstract][Full Text] [Related]
12. Life history of cells mediating natural resistance to tumor cells and bone-marrow transplants: the respective roles of cell lineage commitment and host environment in determining strain characteristics of natural resistance to foreign marrow grafts.
Miller SC
Am J Anat; 1984 Jul; 170(3):367-76. PubMed ID: 6383004
[TBL] [Abstract][Full Text] [Related]
13. Effects of restoring lethally irradiated mice with anti-Thy 1.2-treated bone marrow: graft-vs-host, host-vs-graft, and mitogen reactivity.
Norin AJ; Emeson EE
J Immunol; 1978 Mar; 120(3):754-8. PubMed ID: 24664
[TBL] [Abstract][Full Text] [Related]
14. Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease.
Azuma E; Yamamoto H; Kaplan J
J Immunol; 1989 Sep; 143(5):1524-9. PubMed ID: 2668409
[TBL] [Abstract][Full Text] [Related]
15. Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens.
Thiele DL; Calomeni JA; Lipsky PE
J Immunol; 1987 Oct; 139(7):2137-42. PubMed ID: 3309052
[TBL] [Abstract][Full Text] [Related]
16. A differential requirement for CD8+ donor cells in the augmentation of allograft survival by posttransplantation administration of donor spleen cells and donor bone marrow cells.
Goldstein DR; Chang T; Sweeney SD; Kirklin JK; Thomas JM; George JF
Transplantation; 2000 Oct; 70(7):1068-73. PubMed ID: 11045644
[TBL] [Abstract][Full Text] [Related]
17. Early events in natural resistance to bone marrow transplantation. Use of radiolabeled bone marrow cells.
Carlson GA; Marshall ST; Kiesche A
Transplantation; 1986 Jun; 41(6):688-94. PubMed ID: 2872742
[TBL] [Abstract][Full Text] [Related]
18. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice.
Ohzato H; Monaco AP
Transplantation; 1992 Dec; 54(6):1090-5. PubMed ID: 1465774
[TBL] [Abstract][Full Text] [Related]
19. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
Peres A; Nestel FP; Seemayer TA; Lapp WS
J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
[TBL] [Abstract][Full Text] [Related]
20. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
